0 CHECKOUT

PRODUCT FILTERS

REGION

CATEGORIES

  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

0
0
1
10

PUBLISHED

0
0
0
10

PRODUCT TYPE

10

Search for: "Elan Corporation, plc - Product Pipeline Review - 2012"

Demyelinating Diseases - Pipeline Review, H2 2012

Demyelinating Diseases – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Demyelinating Diseases - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline....

Published:  December 2012
Price:  From

Primary Systemic Amyloidosis - Pipeline Review, H2 2012

Primary Systemic Amyloidosis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Primary Systemic Amyloidosis - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic...

Published:  October 2012
Price:  From

Neurodegenerative Diseases - Pipeline Review, H2 2012

Neurodegenerative Diseases – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Neurodegenerative Diseases - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic...

Published:  September 2012
Price:  From

Neurology - Pipeline Review, H2 2012

Neurology – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Neurology - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information...

Published:  December 2012
Price:  From

Autoimmune Disorders - Pipeline Review, H2 2012

Autoimmune Disorders – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Autoimmune Disorders - Pipeline Review, H2 2012', provides an overview of the Autoimmune Disorders therapeutic pipeline....

Published:  August 2012
Price:  From

Contract Manufacturing in Pharmaceutical Industry, 2015-2025

Amongst the increasing financial pressures and the need to reduce cost and improve efficiencies, the pharmaceutical industry has witnessed a paradigm shift from vertically integrated business model...

Published:  February 2015
Price:  From

Cancer Therapies - Global Strategic Business Report

This report analyzes the worldwide markets for Cancer Therapies in US$ Million by the following Product Segments: Immunotherapy, Targeted Therapy, Hormonal Therapy, and Chemotherapy The report provides...

Published:  October 2011
Price:  From

Therapeutic Monoclonal Antibodies Markets

Antibodies are proteins in the immune system that help the body defend against foreign invasion, particularly from pathogens and toxins. As such, a human-engineered therapeutic monoclonal antibody (mAb)...

Published:  June 2009
Price:  From

Nanotechnology in Drug Delivery - Global Strategic Business Report

This report analyzes the worldwide markets for Nanotechnology in Drug Delivery in US$ Million The Global Market is further analyzed by the following Drug Delivery Technologies: Nanocrystals, and Nanocarriers...

Published:  January 2014
Price:  From

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2013

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q1 2013 Summary Our “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q1 2013”...

Published:  April 2013
Price:  From
Loading Indicator

Our Clients

  • Glanbia Plc.
  • Unilever N.V.
  • Microsoft Corporation
  • Duke University
  • A.T. Kearney
  • PepsiCo Inc.
  • Boston Consulting Group